BLACKROCK Municipal Income TRUST V.BFK.P

Primary Symbol: BFK

BlackRock Municipal Income Trust (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is to provide current income exempt from federal income taxes. Under normal market conditions, the Fund invests at least 80% of its managed assets in investments the income from which is exempt from federal income tax (except that the interest may be subject to the alternative minimum tax). The Fund may invest directly in securities or synthetically through the use of derivatives. The Fund's investment policies provide that it invests at least 80% of its total assets in investment grade quality municipal obligations issued by or on behalf of states, territories and possessions of the United States and their political subdivisions, agencies or instrumentalities, each of which pays interest that, in the opinion of bond counsel to the issuer, is excludable from gross income for federal income tax purposes. Its investment adviser is BlackRock Advisors, LLC.

NYSE:BFK - Post by User

BLACKROCK Municipal Income TRUST > Lisa Marie Langevin ???

<< Previous

Bullboard Posts

Next >>

Comment by HARJAYon Jun 21, 2020 10:44am

133 Views

Post# 31174162

RE:Lisa Marie Langevin ???

Invince

Since sometimes because you write in such a cryptic manner it is difficult to comprehend what you are trying to convey with your posts. If you don't mind can you in plain simple English explain what Lisa Marie Langevin has anything to do with HEXO.

LISA MARIE LANGEVIN, PHD

Lisa Lisa Marie is a Research Coordinator within the Department of Psychology at the University of Calgary. Her research training at the Alberta Children’s Hospital has spanned patient-oriented projects examining prenatal brain development and childhood developmental disorders, through to adolescent mental illness and adult acquired neural injury. Currently Dr. Langevin coordinates the national Advancing Concussion Assessment in Pediatrics (A-CAP) study, which is focused on improving diagnosis, treatment and clinical outcomes in childhood mild traumatic brain injury.